Influence of high serum alpha fetoprotein on patients with gastric cancer
Advances in Digestive Medicine · 2017
DOI: 10.1002/aid2.12050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Digestive Medicine, 2017. Verfasst von Ming‐Yao Chen und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tomorrow Medical Foundation.
Abstract (Originalsprache)
Backgrounds Patients with alphafetoprotein (AFP)‐producing gastric cancer (AFPGC) have a high incidence of liver metastasis and poor prognosis. However, the clinical manifestation of AFPGC remains controversial.
Methods
We enrolled patients who, before surgery, had gastric cancer with serum AFP levels of > 100 ng/mL ( n = 30) and of ≦ 20 ng/mL ( n = 1236). Clinical manifestations were compared between these two groups.
Results
Compared with in the AFP > 100 group, early gastric cancer was more frequent (30.1% vs. 0%) and advanced gastric cancer was less frequent (69.9% vs. 100%) in the AFP ≦ 20 ng/mL group ( p < 0.001). Moreover, the incidence of liver and lymph node metastases was lower in the AFP ≦ 20 ng/mL group than in the AFP > 100 ng/mL group (4.4% vs. 43.3%, p < 0.001 and 60.7% vs. 93.3%, p < 0.001, respectively). More patients had stage IV AFPGC in the AFP > 100 ng/mL group than in the ≦ 20 ng/mL group (66.7% vs 27.1%, p < 0.001). Furthermore, fewer patients underwent curative surgery in the AFP > 100 ng/mL group (6.7% vs 37.9%, p < 0.001). More patients in the AFP > 100 ng/mL group died because of gastric cancer (66.7% vs 27.1%, p < 0.0001).
Conclusions
Patients with very high serum AFP levels have a high incidence of liver and lymph node metastases and extremely poor prognosis. Copyright © 2017, The Gastroenterological Society of Taiwan, The Digestive Endoscopy Society of Taiwan and Taiwan Association for the Study of the Liver.
Förderung
- Tomorrow Medical Foundation
Zitieren
APA
Chen, M., Fang, W., Huang, K., Lai, Y., & Lin, H. (2017). Influence of high serum alpha fetoprotein on patients with gastric cancer. Advances in Digestive Medicine. https://doi.org/10.1002/aid2.12050
Vancouver
Chen M, Fang W, Huang K, Lai Y, Lin H. Influence of high serum alpha fetoprotein on patients with gastric cancer. Advances in Digestive Medicine. 2017. doi:10.1002/aid2.12050
BibTeX
@article{Chen2017,
author = {Chen, Ming‐Yao and Fang, Wen‐Liang and Huang, Kuo‐Hung and Lai, Yu‐Hsin and Lin, Hwai‐Jeng},
title = {Influence of high serum alpha fetoprotein on patients with gastric cancer},
journal = {Advances in Digestive Medicine},
year = {2017},
doi = {10.1002/aid2.12050}
}
EUVIMED